Jakafi — Medical Mutual
Myelofibrosis (MF), including primary MF, post-polycythemia vera MF, and post-essential thrombocytopenia MF
Initial criteria
- Patient is age ≥ 18 years
- Prescribed by or in consultation with a hematologist or oncologist
Approval duration
1 year